- #Intacept 50 mg injection price registration
- #Intacept 50 mg injection price verification
- #Intacept 50 mg injection price free
For more information, visit Media Contact In the domestic market Intas has a leading presence in chronic therapeutic segments and is currently ranked 12th largest company (IMS data). Intas also has extensive presence in more than 60 countries worldwide with robust sales, marketing and distribution infrastructure in highly regulated markets like North America, Europe, South Africa, Australia and New Zealand etc. For the financial year ending March 2015, Intas group is expected to record a turnover of about Rs. Its operations range from API to formulation development to large-scale commercial manufacturing to cater to global requirements. Intas Pharmaceuticals Limited is a leading vertically integrated Indian pharmaceutical company committed on delivering affordable and innovative pharmaceutical solutions.
#Intacept 50 mg injection price registration
In addition, Intas is also the only company from India to have two of its biosimilars, filgrastim and peg-filgrastim filed for registration in the US. INTACEPT is also produced in the same manufacturing facilities as its other biosimilars. The company's biosimilar manufacturing facilities have been approved by global regulatory agencies such as EMA, ANVISA, WHO and others. Its first biosimilar for global markets, Accofil (filgratsim) was launched in Europe in January of this year. Intas is also the only company from India to have registered and launched a biosimilar in the highly regulated European market.
The company continues to have one of the richest pipeline of future products, thereby ensuring cost effective biosimilar alternates to imported and expensive biologic therapies. With the launch of INTACEPT, the company now has nine biosimilar products in the market, including one monoclonal antibody MABTAS (rituximab), the largest indigenously development portfolio of biosimilar products. Intas is one of the pioneers and market leaders of biosimilars in India, having launched its first product in the domestic market in 2004.
Through INTACEPT, we are able to reduce the cost of treatment for patients to about half of the imported Enbrel®." INTACEPT is a further validation of our world-class R&D and manufacturing capabilities that bring global healthcare standards to Indian patients at a lower cost. Binish Chudgar, Vice-Chairman of the Company, said, "Etanercept is a fusion protein that is difficult to develop. Etanercept is indicated for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Plaque Psoriasis, all debilitating autoimmune diseases.
#Intacept 50 mg injection price free
INTACEPT, Intas' etanercept, has been launched in two strengths, 25mg in 0.5 ml and 50 mg in 1.0 ml preservative free solution, in easy to use pre-filled syringes. XOSPATA (gilteritinib) tablets in Australia and New Zealand.Intas Pharmaceuticals today announced that they have launched INTACEPT, the first biosimilar to Amgen's Enbrel® (etanercept). XOSPATA (gilteritinib) tablets in African Countries – Algeria, Mauritius, Uganda, Zimbabwe. XOSPATA (gilteritinib) tablets in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia. XOSPATA (gilteritinib) tablets in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
XOSPATA (gilteritinib) tablets in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela. XOSPATA (gilteritinib) tablets in North America – Mexico. VENCLEXTA (venetoclax) tablets in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan. Send your query to find the best price of – The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.Ĭan I get anti-cancer medicines even if I am not based in India?Īlmost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. You will get reply within few hours with pricing and procedure details.
To buy VENCLEXTA ™ (venetoclax) tablets, patients can simply fill the order form or can send mail at or can also send Whatsapp message at +91 96677 50889. Procedure to buy VENCLEXTA ™ (venetoclax) tablets?
#Intacept 50 mg injection price verification
Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. This indication is approved under accelerated approval based on overall response rate. VENCLEXTA is a BCL-2 inhibitor indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy. VENCLEXTA is used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
0 kommentar(er)
